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Matrix metalloproteinase-9 (MMP-9), a type of gelatinase, plays many roles in tissue metabolism, especially in
inﬂammation, and many regulatory elements have been reported in the promoter region of its encoding gene.
Leptomycin B, which regulates the nucleo-cytoplasmic trafﬁcking of proteins, including transcription-factor-re-
lated ones, has the potential to exert important biological effects. The addition of leptomycin B to keratinocytes in
culture had no effect on matrix metalloproteinase-2 (another gelatinase) but caused the selective down-regulation
of MMP-9 during the stimulation of differentiation with high Ca2þ or transforming growth factor-b, as well as during
the stimulation of inﬂammation by tumor necrosis factor-a or interleukin-1a. This down-regulation depended on
multiple regulatory elements in the promoter of MMP-9 including KRE-M9 (which we have recently identiﬁed), and a
classical 12-o-tetradecanoyl-phorbol-13-acetate-responsive element. The topical application of leptomycin B to
murine skin also effectively suppressed inﬂammation, including MMP-9 expression, after ultraviolet B irradiation.
These results suggest that the application of leptomycin B and/or its derivatives could be useful for treating many
inﬂammatory conditions.
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In a variety of organs, matrix metalloproteinase (MMP)-9
(also known as gelatinase B) has been reported as an im-
portant enzyme involved in the pathophysiology of tissue
metabolism (McCawley and Matrisian, 2001), which in-
cludes tumor invasion and metastasis (Wilhelm et al, 1989;
Salo et al, 1991; Sato and Seiki, 1993; Kobayashi et al,
1996; Coussens et al, 2000), the inflammation in bullous
diseases (Sta˚hle-Ba¨ckdahl et al, 1994; Liu et al, 1998;
Verraes et al, 2001), and in ultraviolet (UV) B-related de-
rmatoses (Fisher et al, 1996, 1997; Onoue et al, 2003). We
have reported the induction of MMP-9 expression during
the differentiation of keratinocytes (Kobayashi et al, 1996,
2001, 2004), which occasionally reflects dyskeratosis, ab-
normalities of the fine mechanism of programmed cell death
as inflammatory, and/or oncogenic reactions in the epider-
mis (Kobayashi et al, 1996; Coussens et al, 2000). In ad-
dition to keratinocytes, a wide variety of MMP-9 expressing
cells have been reported, such as tumor cell lines and po-
lymorphonuclear leukocytes as well as cytokine-induced
fibroblasts in inflammation (Wilhelm et al, 1989; Salo et al,
1991; Sato and Seiki, 1993; Sta˚hle-Ba¨ckdahl et al, 1994;
Kobayashi et al, 1996, 2003; Segain et al, 1996; Coussens
et al, 2000; Liu et al, 1998; Han et al, 2001; McCawley and
Matrisian, 2001; Verraes et al, 2001). Thus, inhibition of
MMP-9 function may be an important approach to manage
many dermatoses (Bergers et al, 2002; Vayalil et al, 2004).
In comparison with MMP-2, another type of gelatinase
(known as gelatinase A) (McCawley and Matrisian, 2001),
many regulatory elements have been reported to control
MMP-9 transcription including KRE-M9 and 12-o-tetrad-
ecanoyl-phorbol-13-acetate (TPA)-responsive elements
(TRE) in the MMP-9 promoter (Sato and Seiki, 1993; Sato
et al, 1993; Yokoo and Kitamura, 1996; Gum et al, 1997;
Himelstein et al, 1997; Han et al, 2001; Kobayashi et al,
2001, 2004), which could play pathophysiological roles in
regulating MMP-9 expression.
Leptomycin B (LMB), initially identified as an anti-fungal
substance (Hamamoto et al, 1983a, b), has been reported to
suppress the nuclear export of proteins that contain nuclear
export signals, including transcription-factor-related pro-
teins (Nishi et al, 1994; Fornerod et al, 1997a, b; Ullman
et al, 1997; Greber and Carafoli, 2002). Thus, LMB is con-
sidered to potentially function in vivo and might exert many
different biological effects. But the role of LMB in the actual
metabolism of the extracellular matrix has not yet been
elucidated, although it has been reported to potentially in-
hibit the proliferation of tumor cells (Komiyama et al, 1985;
Yoshida et al, 1990). We speculated that LMB could influ-
ence the induction of MMP-9 expression, which is control-
led by many gene-regulatory elements.
In this study, the effects of LMB both on MMP-9 ex-
pression in primary human keratinocytes as well as in fib-
roblasts in culture and on the inflammation of murine skin
after UVB irradiation were examined.
Abbreviations: IL-1a, interleukin-1a; LMB, leptomycin B; MMP,
matrix metalloproteinase; TGF-b, transforming growth factor-b;
TNF-a, tumor necrosis factor-a; TRE, 12-o-tretradecanooyl-phor-
bol-13-acetate (TPA)-responsive element; UV, ultraviolet
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Results
Induction of MMP-9 activity from keratinocytes and from
ﬁbroblasts following metabolic stimulation and its ab-
rogation by LMB The gelatin-zymography method quan-
titatively analyzes gelatinase activity, as reported previously
(Fig 1A) (Kleiner and Stetler-Stevenson, 1994; Kobayashi
et al, 2001, 2004; Kobayashi, 2004). High Ca2þ or the ad-
dition of transforming growth factor (TGF)-b to the culture
medium are known to stimulate the differentiation of kera-
tinocytes (Benassi et al, 1997; Kobayashi et al, 2001, 2004),
a kind of programmed cell death. The addition of tumor
necrosis factor (TNF)-a or interleukin (IL)-1a is known to
cause apoptotic and/or inflammatory responses (Muegge
et al, 1993; Verrecchia et al, 2002). All these stimulations,
which are considered to elicit cutaneous metabolism during
inflammation, induce the selective expression of MMP-9 in
comparison with MMP-2 (Fig 1B), although a slight induc-
tion of MMP-2 by TGF-b was also observed. We have also
reported the same selective induction of MMP-9 activity by
UVB irradiation (Onoue et al, 2003).
Following the addition of LMB (especially at 2 or 10 nM)
to keratinocytes in culture, gelatin-zymography of condi-
tioned media collected for 24 h showed the selective re-
duction of MMP-9 activity compared with MMP-2 activity
(Fig 1C). This effect of LMB was shown to be dose-de-
pendent in all cases, i.e., during high Ca2þ stimulation, the
addition of TGF-b (Fig 2A, B) or the addition of TNF-a or IL-
1a (Fig 2C, D). The induced activity of MMP-9 from fibro-
blasts in culture by the additions both of TGF-b and of TNF-
a was also reduced by treatment with LMB (Fig 2E).
Reduction of MMP-9 mRNA in keratinocytes by
LMB Quantitative RT-PCR showed that the level of MMP-
9 mRNA was increased after stimulation with high Ca2þ , or
after the addition of TGF-b, TNF-a, or IL-1a (Fig 3). On the
other hand, the addition of LMB reduced MMP-9 mRNA
levels in all conditions tested, including the aforementioned
stimuli (Fig 3). These results are in accordance with the
changes in MMP-9 secretion noted at the protein level by
zymography, and indicate the reduction of MMP-9 tran-
scription elicited by LMB. We confirmed that the mRNA
levels of tissue inhibitor of metalloproteinases (TIMP)-1,
known as a relatively specific inhibitor for MMP-9 by form-
ing the complex of MMP-9 and TIMP-1 molecules with a
stoichiometry of 1:1 on a molar basis (Kleiner and Stetler-
Stevenson, 1993), were not significantly changed under the
conditions described above using quantitative RT-PCR
(data not shown). These results indicate that the low level
of relative MMP-9/TIMP-1 ratio in mRNA expression by
LMB could potentially reflect the suppressed enzymatic
activity of MMP-9, although we cannot deny the possibility
that TIMP-1 activity itself could be regulated by any other
mechanism including the protein degradation (Okada et al,
1988).
Synergistic reduction of MMP-9 transcription by LMB
through multiple elements in the MMP-9 promoter To
identify the element in the MMP-9 promoter responsible for
the reduction in MMP-9 transcription elicited by LMB, lucif-
erase assays were performed using keratinocytes in culture.
As we have reported previously (Kobayashi et al, 2001,
2004), transcriptional activity without KRE-M9 was lost us-
ing constructs of small fragments near the transcription in-
itiation site (Fig 4A). Following treatment with LMB, the
down-regulation of MMP-9 promoter activity with KRE-M9
was observed (Fig 4A). In addition, the TRE with a mutated
KRE-M9 element was also shown to be responsive to the
down-regulation by LMB (Fig 4B).
Moreover, an element further upstream was also shown
to be responsive to LMB using constructs of mutations both
in the KRE-M9 and in the TRE near the transcription initi-
ation site (Fig 4C). These results indicate that the reduction
Figure 1
Induction of matrix metalloproteinase (MMP)-9 activity in vitro by
metabolic stimuli and reduction by leptomycin B (LMB). (A) 1500 pg
(lane 1500), 500 pg (lane 500), or 170 pg (lane 170) of human recom-
binant MMP-9 was applied and quantitative intensities of clear bands
by their gelatinolytic activities are shown. The quantitation is shown in
the lower panel. (B) Aliquots of conditioned culture media of keratin-
ocytes stimulated by high Ca2þ (lanes Ca) or by the addition of trans-
forming growth factor-b (TGF)-b (lanes TGF), tumor necrosis factor-a
(TNF)-a (lanes TNF) or interleukin-1a (IL-1)a (lanes IL1), or without stim-
ulation (lanes Con). The quantitation of MMP-9 is shown in the lower
panel. Induction of MMP-9 activity was observed in all stimulated con-
ditions. (C) Selective reduction of MMP-9 activity compared with MMP-
2 activity was observed by the addition of LMB to keratinocytes. The
quantitations of MMP-9 and MMP-2 are shown in the lower panel. In (B)
and (C), arrowheads between the MMP-9 and MMP-2 bands on the
right show the partially degraded MMP-9. Experiments were performed
in triplicate for each condition (B, C).
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of MMP-9 transcription elicited by LMB is regulated by
multiple gene regulatory elements in the MMP-9 promoter.
Suppression of UVB irradiation-induced inﬂammatory
response by topical LMB application The effects of top-
ical LMB application on cutaneous inflammation in vivo
were examined in an inflammatory model using hairless
murine skin 48 h after UVB irradiation. In hematoxylin–eo-
sin-stained specimens, UVB-irradiated skin showed an ab-
normal polarity, morphological changes on the programmed
cell death of keratinocytes, including dyskeratosis in the
epidermis, and marked inflammation with many leukocytic
infiltrates, especially around the blood vessels, both in the
dermis and in the fat tissue compared with non-irradiated
Figure 2
Suppression of induced matrix metalloproteinase (MMP-9) activity
from cultured keratinocytes by leptomycin B (LMB). Aliquots of
conditioned culture media of keratinocytes stimulated by high Ca2þ (A)
or by the addition of transforming growth factor-b (TGF-b) (B), tumor
necrosis factor-a (TNF)-a (C), or interleukin-1a (IL-1a) (D) and of fibro-
blasts stimulated both by TGF-b and by TNF-a (E) in the absence (lanes
0) or the presence of LMB (0.4 nM (lanes 0.4), 2 nM (lanes 2), 10 nM
(lanes 10)) were analyzed by gelatin-zymography. The quantitations of
MMP-9 are shown in the lower panels. Reduction of MMP-9 activity
was observed in comparison with no LMB (lanes 0). Arrowheads be-
tween the MMP-9 and MMP-2 bands show the partially degraded
MMP-9. Experiments were performed in triplicate (A, B, C, D) or in
duplicate (E) for each condition.
Figure3
Reduction of matrix metalloproteinase (MMP)-9 mRNA expression
in cultured keratinocytes treated with leptomycin B (LMB). Quan-
titative RT-PCR analyses for the quantitation of MMP-9 mRNA were
performed. The vertical axis shows the relative intensities after adjust-
ment for the amount of b-actin cDNA using total RNA from cultured
keratinocytes after stimulation with Ca2þ , transforming growth factor-
b, tumor necrosis factor-a, or nothing (Con). In comparison with no
addition of LMB (columns ), the expression of MMP-9 mRNA was
suppressed by the addition of LMB (columns þ ).
Figure4
Reduction of matrix metalloproteinase (MMP-9) transcription by
multiple gene regulatory elements. Using a luciferase assay for cul-
tured keratinocytes and the MMP-9 promoter region, KRE-M9 was
shown to be responsible not only for basal MMP-9 transcriptional ac-
tivity but also for the downregulation by LMB (A). Not only the KRE-M9
element but also tretradecanooyl-phorbol-13-acetate (TPA)-responsive
element (TRE) and the other element were shown to be responsible for
the down-regulation of leptomycin B (LMB) in MMP-9 transcription after
transfection of 80 to þ16 (B) and 714 to þ 16 (C) sequences with
(þ ) or without () LMB. All these changes were shown to be statis-
tically significant. S4 in KRE-M9 element (B, C) and S3 in 12-o-TRE (C)
are the substitutions of four bases for KRE-M9 and of three bases for
TRE, respectively. The length of each column on the right shows the
average of triplicate data. Error bars indicate the SD.
SUPPRESSION OF INFLAMMATION BY LEPTOMYCIN B 333124 : 2 FEBRUARY 2005
skin (Fig 5A, B). In skin treated twice topically with LMB (2
mM), these inflammatory effects of UVB irradiation were al-
most completely suppressed everywhere in the skin, in-
cluding the epidermis, the dermis and the fat tissue (Fig 5C).
No significant changes were observed in non-irradiated skin
with or without LMB treatment (Fig 5B, D). These anti-in-
flammatory effects of LMB were confirmed at a dose of 20
mM (data not shown). These effects, however, were shown
to be obseved in a concentration-dependent manner, and
were attenuated at lower doses (200 nM). The loss of po-
larity in the epidermis together with moderate infiltrates of
inflammatory cells in the subepidermis was observed at
20 nM LMB (Fig 5E, G). There were no significant changes
in the skin without UVB irradiation after the application of
LMB at these concentrations (Fig 5F, H).
Reduction of MMP-9 activity in the skin after the anti-
inﬂammatory effects elicited by LMB To determine the
actual effects on MMP-9 activity in the skin elicited by LMB,
gelatin-zymography was performed using murine skin tis-
sues. After UVB irradiation, murine MMP-9 expression was
observed as the major gelatinolytic activity (Fig 6A). Topical
application of LMB (2 mM), however, decreased MMP-9 ac-
tivity. Although MMP-2 secretion as a minor gelatinolytic
activity (following prolonged reaction in the gelatin-contain-
ing gel after electrophoresis) was also induced slightly by
UVB, there was no significant effect of LMB to reduce
MMP-2 (Fig 6B).
Discussion
Control of cutaneous inflammation is one of the most mo-
mentous problems for many physicians. MMP-9, a type of
gelatinase, has been considered to play important roles in
tissue metabolism during inflammation. For example, MMP-
9 has been reported to cleave not only extracellular matrix
components such as denatured collagen (gelatin), type IV, V,
and VII collagens, elastin, and fibronectin but also converts
the proforms of many cytokines such as TGF-b, TNF-a, and
Figure 5
Suppression of cutaneous inflammation after
ultraviolet B (UVB) irradiation by leptomycin B
(LMB). Histological specimens of murine skin
without (A, B) or with (C, D, E, F, G, H) the ap-
plication of LMB after UVB irradiation (A, C, E, G)
or unirradiated (B, D, F, H) (hematoxylin–eosin
staining). The dorsal aspects of hairless mice
were irradiated by UVB at a dose of 300 mJ, and
topical LMB was applied at 2 mM (C, D), 200 nM
(E, F), or 20 nM (G, H) twice, just after irradiation
and 24 h later. Skin specimens were harvested at
48 h after UVB irradiation or unirradiated. Scale
bar¼100 mm. Although the UVB-irradiated skin
without LMB application (A) showed dyskerato-
sis in the epidermis and inflammatory cell infil-
trates both in the dermis and in the adipose
tissue compared with skin without UVB irradia-
tion (B), the application of LMB successfully
reduced these inflammatory effects of UVB irra-
diation on the skin in a concentration-dependent
manner (C, E, G). No significant changes in the
skin were observed with or without treatment
with LMB without UVB irradiation (D, F, H).
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IL-1a into their active forms (McCawley and Matrisian,
2001). These cytokines can then up-regulate MMP-9 ex-
pression in many types of cells, including keratinocytes and
fibroblasts, as reported here and as previously reported
(Salo et al, 1991; Segain et al, 1996; Han et al, 2001;
Kobayashi et al, 2003).
Under these circumstances, it is easy to imagine the au-
tocrine effects on the upregulation of MMP-9 expression
through the activation of cytokines, and the control of MMP-
9 expression is considered to be important for the man-
agement of many inflammatory diseases, as well as con-
trolling tumor invasion and/or metastasis. In fact, fewer
metastases of tumors in MMP-9 null mice were reported
following the loss of MMP-9 expression from inflammatory
cells rather than from tumor cells (Coussens et al, 2000). No
blister formation was reported in MMP-9 null mice using the
bullous pemphigoid model (Liu et al, 1998). In addition, UVB
irradiation, which is known to cause cutaneous inflamma-
tion, also upregulates MMP-9 expression (Fisher et al, 1996,
1997; Onoue et al, 2003). The data presented here show
therapeutic control in this inflammatory model by topical
application of LMB, not only of subepidermal inflammatory
cell infiltrates but also of epidermal dyskeratosis, both of
which are considered to result from the induced MMP-9
expression. But the effects of LMB on other inflammatory
conditions should be further examined.
LMB, which is an unsaturated, branched-chain fatty acid
originally found as an anti-fungal substance (Hamamoto
et al, 1983a, b), has also been reported to suppress cell
proliferation (Komiyama et al, 1985; Yoshida et al, 1990) and
a phase I trial of LMB therapy was performed in patients
with malignant tumors (Newlands et al, 1996). The primary
side-effects at that time were reported to be nausea and
anorexia during systemic treatment (Newlands et al, 1996).
LMB is now known to bind to CRM1 and to prevent the
nuclear export of proteins with nuclear export signals, which
includes transcriptional regulators (Nishi et al, 1994; Forne-
rod et al, 1997a, b; Ullman et al, 1997). Here, we show that
the newly identified KRE-M9 element as well as the clas-
sical TRE is at least responsible for the inhibition of MMP-9
transcription by LMB, and we speculate that the KRE-M9
binding protein, our designated differentiation repressing
factor 1 (DRF-1), could be kept in the nucleus by LMB
(Kobayashi et al, 2004).
In comparison with MMP-9 expression, our results
showed no significant changes for MMP-2 expression ei-
ther on cells in culture and on the UVB-irradiated skin. Dif-
ferences in the biological effects between MMP-2 and
MMP-9, which have been reported to have the same subst-
rate specificity in vitro, should be further clarified. A variety
of inhibitors of enzymatic activity or of the production in
MMP-9 have been reported (Bergers et al, 2002; Vayalil
et al, 2004) and those materials should also be tested for
effects on inflammation. LMB, which reduces MMP-9 ex-
pression at the transcriptional level, as reported here, could
be the optimal treatment for inflammation, not only for the
skin but also for other epithelial tissues such as the bronchi
and the gut. This report shows the effectiveness of LMB on
inflammation, although other aspects of the cause of the
anti-inflammatory effect might exist and should be further
clarified.
In conclusion, the application of LMB or of its derivatives
could be a useful remedy for many pathological conditions
in which MMP-9 is involved.
Materials and Methods
Culture of cells Newborn human epithelial keratinocytes from
foreskins (NHEK(F)) were purchased from Kurabou (Osaka, Japan)
and were cultured in keratinocyte-SFM medium (Life Technologies,
Gaithersburg, Maryland), containing 0.09 mM Ca2þ . To stimulate
keratinocytes in culture, the Ca2þ concentration was increased to
1.5 mM or the medium was supplemented with TGF-b (1 ng per
mL) (Sigma, St Louis, Missouri), TNF-a (10 ng per mL) (Sigma), or
IL-1a (1010 M) (Sigma). LMB (Sigma) was added to a final con-
centration of 0.4 nM, 2 nM, or 10 nM for gelatin-zymography and to
5 nM for the harvest of total RNA. Conditioned medium was col-
lected for 24 h and was used for gelatin-zymography or the cells
Figure 6
Suppression of ultraviolet B (UVB)-induced matrix metallo-
proteinase (MMP)-9 activity in the skin by leptomycin B (LMB). (A)
In gelatin-zymography from the murine skin, UVB irradiation induced
MMP-9 acitivity as a major band (lanes UVB) in comparison with no
irradiation (lanes Con). Following LMB application, the increased MMP-
9 activity was suppressed (lanes LMB). (B) MMP-2 (seen as a minor
band following prolonged reaction of the gelatin containing gel) is also
induced by UVB irradiation to some extent, but no suppression by LMB
is observed. The quantitations are shown in the lower panels. Exper-
iments were performed in duplicate for each condition.
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were incubated for 24 h prior to the harvest of total RNA. Human
fibroblasts derived from outgrowths of normal human dermis were
cultured in Dulbecco’s modified Eagles medium (Life Technologies)
with 10% fetal calf serum. Conditioned serum-free medium sup-
plemented with TGF-b (1 ng per mL) and with TNF-a (10 ng per mL)
was collected for 48 h for gelatin-zymography.
Zymography using gelatin Gelatin-zymography was performed
as previously reported (Kobayashi et al, 2003, 2004; Kobayashi,
2004). Briefly, samples of human recombinant MMP-9 (Genzyme
Techne, Cambridge, Massachusetts), of conditioned medium, or of
homogenates from murine skin (10 mg per lane) were separated
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis on
7.5% gels containing 0.5% gelatin. After electrophoresis, the gels
were washed with 2.5% Triton X-100 for 1 h. Gelatinolytic zymo-
graphy reactions were induced by incubating the gels in the re-
action buffer (0.05 M Tris-HCl, pH 7.4, 0.15 M NaCl, 5 mM CaCl2,
and 0.02% NaN3) at 351C for appropriate periods (usually several
h). Gels were then stained with 0.1% amido black B-10 and de-
stained with 10% acetic acid/30% methanol. The intensity of the
bands was quantified using NIH image 1.55 and the content of
MMP-2 or 9 was calculated by comparison with known amounts of
human recombinant MMP-9, as previously reported (Kobayashi
et al, 2003).
Real-time RT-PCR Total RNA was extracted from each keratin-
ocyte culture as described above using an RNeasy kit (Qiagen,
Hilden, Germany). RT reactions were performed using 1 mg total
RNA (TaKaRa, Osaka, Japan). PCR amplifications were performed
using each gene-specific primer (TaKaRa). Primers of the following
sequences were used: MMP-9 forward (50-AAGATGCTGCTG-
TTCAGCGGG-30) and reverse (50-GTCCTCAGGGCACTGCAG-
GAT-30) (Wilhelm et al, 1989), TIMP-1 forward (50-AGCGCCCAGA-
GAGACACC-30) and reverse (50-CCACTCCGGGCAGGATT-30)
(Wong et al, 2001), and b-actin forward (50-CAGGCTGTGCTAT-
CCCTGTAC-30) and reverse (50-CACGCACGATTTCCCGCTCGG-
30) (Lacelle and Polakowska, 2001). b-actin expression was used to
normalize the amounts of cDNAs. After confirmation of single
bands in electrophoresis, quantitative real-time RT-PCR were
performed on a DNA Engine Cycler (MJ Research, Waltham, Mas-
sachusetts) according to the manufacturer’s instructions. The an-
nealing temperature was set for 551C. Representative data are
shown from at least duplicate experiments.
Luciferase assay The 730-base pair (bp) fragments of the human
MMP-9 promoter (714 to þ 16), which includes the TRE (80
to 74, 50-TGAGTCA-30), the KRE-M9 (66 to 57, 50-
GCCTGTCAAG-30), and shorter fragments (80 to þ 16, 73 to
þ 16, and 56 to þ 16) together with fragments containing mu-
tated sequences (S3 for TRE, 50-TGAGCAT-30; S4 for KRE-M9, 50-
GAATTCCAAG-30), were inserted into the pGL3-Basic vector
(Promega, Madison, Wisconsin) as previously reported (Kobayashi
et al, 2001, 2004). Subconfluent cells were grown in 48-well plastic
tissue culture plates and 0.1 mg DNA per well was transfected
using the FuGENE Transfection Reagent (Roche Diagnostics, Man-
nheim, Germany) as per the manufacturer’s recommendations. Af-
ter 6 h, each well was washed with phosphate-buffered saline, and
then with fresh medium after which final fresh medium was added
to each well, with or without the addition of LMB (5 nM) as de-
scribed above. Twenty-four hours later, luciferase activities were
measured by the luciferase assay system (Promega). Each value
reported is the average of triplicate data.
UVB irradiation-induced inﬂammation in vivo The effects of
topical LMB application on cutaneous inflammation in vivo were
examined in the typical inflammatory model using hairless murine
skin after UVB irradiation as follows. Hairless mice (Hos: HR-1)
aged 8 wk were kept for a week before irradiation. The dorsal
aspects of mice were then irradiated by UVB at a dose of 300 mJ
(approximately three times the minimal erythema dose). LMB, pre-
pared as previously reported (Hamamoto et al, 1983a), was applied
topically at 10 mg per mL (20 mM), 1 mg per mL (2 mM), 100 ng per
mL (200 nM), or 10 ng per mL (20 nM), diluted with ethanol
just before application. The applications were performed twice: just
after the UVB irradiation and 24 h later. Skin specimens were har-
vested with or without the application of LMB at 48 h after UVB
irradiation (or unirradiated as a control). Specimens for patholog-
ical examination were fixed in 10% formalin, and embedded in
paraffin, sectioned and stained with hematoxylin–eosin. Speci-
mens for gelatin-zymography were prepared by the homogeniza-
tion of skin specimens in Tris-HCl, pH 7.5, with 0.15 M NaCl. All
experiments were performed with institutional approval.
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